Literature DB >> 11447158

Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.

D P Fonseca1, B Benaissa-Trouw, M van Engelen, C A Kraaijeveld, H Snippe, A F Verheul.   

Abstract

Cell-mediated immune responses are crucial in the protection against tuberculosis. In this study, we constructed DNA vaccines encoding cytotoxic T lymphocytes (CTL) and T helper cell (Th) epitopes of the 38-kDa lipoglycoprotein of Mycobacterium tuberculosis and analyzed and compared their immunogenicities with that of pXJ38, a DNA vaccine encoding the entire 38-kDa protein (X. Zhu, N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier, J. Immunol. 158:5921-5926, 1997). Plasmid DNAs encoding a CTL epitope, P3 (pP3), a Th epitope (vTh), or both the Th and the P3 epitopes (pThP3) were prepared and tested in C57BL6/J (H-2(b)) mice. Our results confirmed that DNA immunization with pXJ38 induces strong CD8(+) CTL and Th1 responses (high gamma interferon [IFN-gamma], low interleukin-4 [IL-4]). Coadministration of plasmid DNAs encoding a Th epitope with those encoding a CTL epitope (vTh+pP3) elicited both antigen-specific CD8(+) CTL and Th1 responses. High levels of IFN-gamma were secreted by spleen cells from all plasmid DNA-vaccinated mice after in vitro stimulation with the recombinant 38-kDa protein. Small or undetectable amounts of IL-4 were observed, which indicates the induction of a Th1-like response. Multiple-epitope vaccination by vTh+pP3 or pThP3 resulted in a broader Th1 response to peptide or epitopes than the single-epitope plasmid DNAs. Antigen-specific immunoglobulin G2a was only detected in sera from mice immunized with the plasmid pXJ38, and not in mice immunized with the epitope-based DNA vaccines. Thus, the absence of an antibody response after immunization with epitope plasmid DNAs and their ability to trigger only a specific cellular immune response may prove to be important advantages for a vaccine against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447158      PMCID: PMC98572          DOI: 10.1128/IAI.69.8.4839-4845.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

Authors:  M Roman; E Martin-Orozco; J S Goodman; M D Nguyen; Y Sato; A Ronaghy; R S Kornbluth; D D Richman; D A Carson; E Raz
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

Review 2.  Immunobiology of interleukin-12.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

3.  Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.

Authors:  S A Thomson; M A Sherritt; J Medveczky; S L Elliott; D J Moss; G J Fernando; L E Brown; A Suhrbier
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection.

Authors:  X Zhu; N Venkataprasad; H S Thangaraj; M Hill; M Singh; J Ivanyi; H M Vordermeier
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

5.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

Authors:  E Lozes; K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; P Vandenbussche; J P Van Vooren; A Drowart; J B Ulmer; M A Liu
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

7.  Protection against tuberculosis by a plasmid DNA vaccine.

Authors:  D B Lowrie; C L Silva; M J Colston; S Ragno; R E Tascon
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

8.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

9.  Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.

Authors:  R D Cardin; J W Brooks; S R Sarawar; P C Doherty
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.

Authors:  S R Bennett; F R Carbone; F Karamalis; J F Miller; W R Heath
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  10 in total

Review 1.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.

Authors:  Courtney L Erskine; Christopher J Krco; Karen E Hedin; Nancy D Borson; Kimberly R Kalli; Marshall D Behrens; Sabrina M Heman-Ackah; Eric von Hofe; Peter J Wettstein; Mansour Mohamadzadeh; Keith L Knutson
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

Review 5.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 6.  Next generation: tuberculosis vaccines that elicit protective CD8+ T cells.

Authors:  Samuel M Behar; Joshua S M Woodworth; Ying Wu
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

7.  Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients.

Authors:  Anbarasu Deenadayalan; Darragh Heaslip; Adhilakshmi Aavudaiyappan Rajendiran; Banurekha Vaithilingam Velayudham; Sheela Frederick; Hong-Liang Yang; Karen Dobos; John T Belisle; Alamelu Raja
Journal:  Mol Cell Proteomics       Date:  2009-12-22       Impact factor: 5.911

8.  Docking studies and network analyses reveal capacity of compounds from Kandelia rheedii to strengthen cellular immunity by interacting with host proteins during tuberculosis infection.

Authors:  Aubhishek Zaman
Journal:  Bioinformation       Date:  2012-10-31

9.  Therapeutic effects of mycobacterial secretory proteins against established asthma in BALB/c mice.

Authors:  Eui-Ryoung Han; Inseon S Choi; Han-Gyu Choi; Hwa-Jung Kim
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-19       Impact factor: 5.764

10.  Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.

Authors:  Rakhee Sachdeva; Akhil C Banerjea; Nancy Malla; Mohan Lal Dubey
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.